United States Biotechnology & Medical Research

Track

Transcode Therapeutics Inc (RNAZ)

Track

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: RNAZ Exchange: NAS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Fitzgerald Thomas A

Chief Financial Officer

1 purchase — total 25,169 USD

Buy 28 Sep 2023

Value US$2,231,890.97 | Price 410.95 | Shares 37,988

Dudley Robert Michael

Chief Executive Officer

1 purchase — total 49,980 USD

Buy 28 Sep 2023

Value US$2,147,934.01 | Price 34.49 | Shares 3,860

Dudley Robert Michael

Chief Executive Officer

1 purchase — total 31,818 USD

Buy 21 Jun 2023

Value US$31,818.00 | Price 2.65 | Shares 12,000

Dudley Robert Michael

Chief Executive Officer

1 purchase — total 16,847 USD

Buy 20 Jun 2023

Value US$16,846.53 | Price 2.55 | Shares 6,607

Dudley Robert Michael

Chief Executive Officer

1 purchase — total 52,440 USD

Buy 9 Jun 2023

Value US$52,440.00 | Price 2.76 | Shares 19,000

Dudley Robert Michael

Chief Executive Officer

1 purchase — total 23,000 USD

Buy 14 Sep 2022

Value US$23,000.00 | Price 1.15 | Shares 20,000

Fitzgerald Thomas A

Chief Financial Officer

1 purchase — total 15,240 USD

Buy 16 Jun 2022

Value US$15,240.00 | Price 1.27 | Shares 12,000

Dudley Robert Michael

Chief Executive Officer

1 purchase — total 3,740 USD

Buy 31 May 2022

Value US$3,739.80 | Price 1.87 | Shares 2,000

Dudley Robert Michael

Chief Executive Officer

1 purchase — total 51,643 USD

Buy 27 May 2022

Value US$51,643.20 | Price 1.84 | Shares 28,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2023-10-02	2023-09-28	B Purchase	1.5 Fitzgerald Thomas A Chief Financial Officer Executive Director	37,988 +6.0% 410.95 US$2,231,891	37,988 +6.0%	410.95	US$2,231,891
2023-10-02	2023-09-28	B Purchase	0.9 Dudley Robert Michael Chief Executive Officer Executive Director	3,860 -26.9% 34.49 US$2,147,934	3,860 -26.9%	34.49	US$2,147,934
2023-06-22	2023-06-21	B Purchase	0.9 Dudley Robert Michael Chief Executive Officer Executive Director	34,025 -43.4% 390.03 US$2,095,094	34,025 -43.4%	390.03	US$2,095,094
2023-06-22	2023-06-20	B Purchase	0.9 Dudley Robert Michael Chief Executive Officer Executive Director	6,607 +10.4% 2.55 US$16,847	6,607 +10.4%	2.55	US$16,847
2023-06-13	2023-06-09	B Purchase	0.9 Dudley Robert Michael Chief Executive Officer Executive Director	19,000 +2.1% 2.76 US$52,440	19,000 +2.1%	2.76	US$52,440
2022-09-16	2022-09-14	B Purchase	0.9 Dudley Robert Michael Chief Executive Officer Executive Director Large shareholder	20,000 +2.3% 1.15 US$23,000	20,000 +2.3%	1.15	US$23,000
2022-06-17	2022-06-16	B Purchase	1.5 Fitzgerald Thomas A Chief Financial Officer Executive Director	12,000 +9.4% 1.27 US$15,240	12,000 +9.4%	1.27	US$15,240
2022-06-01	2022-05-31	B Purchase	0.9 Dudley Robert Michael Chief Executive Officer Executive Director Large shareholder	2,000 +0.2% 1.87 US$3,740	2,000 +0.2%	1.87	US$3,740
2022-06-01	2022-05-27	B Purchase	0.9 Dudley Robert Michael Chief Executive Officer Executive Director Large shareholder	28,000 +3.3% 1.84 US$51,643	28,000 +3.3%	1.84	US$51,643